CASE REPORT: PRESERFLO AB-EXTERNO MICROSHUNT IMPLANTATION IN PATIENT WITH ADVANCED GLAUCOMA- IS IT A WAY TO GO?

Published 2022 - 26th ESCRS Winter Meeting

Reference: P256 | Type: Abstracts | DOI: 10.82333/ck1m-tb30

Authors: Anna Mikolajczyk* ¹ , Wojciech Wiktor Maruszczyk ¹ , Mariola Dorecka ² , Ewa Izabela Mrukwa-Kominek ²

¹Department of Ophthalmology,Prof. K. Gibinski University Clinical Centre, Katowice, Poland,Katowice,Poland, ²Department of Ophthalmology,Prof. K. Gibinski University Clinical Centre, Katowice, Poland,Katowice,Poland;Department of Ophthalmology,Faculty of Medical Sciences in Katowice, Medical University of Silesia,Katowice,Poland

Purpose

To present a report of the attempt to reduce and stabilize intraocular pressure in patient with advanced, glaucomatous optic neuropathy and severe field impairment by implanting Preserflo Ab-Externo Microshunt.

Setting

Prof. K. Gibinski University Medical Centre, Department of Ophthalmology, Medical University of Silesia in Katowice, Poland.

Methods

A 77-year old woman, hospitalized because of high intraocular pressure in the right eye with advanced neuropathy. By admission, best corrected visual acuity in the right eye was 0,3 and the intraocular pressure was 25 mm Hg on maximal topical therapy. After the thorough assessment and examination, patient had been qualified to the microinvasive glaucoma surgery- implantation of Preserflo Ab- Externo Microshunt in the right eye. The surgical procedure was performed without complications, obtaining the lowering and stabilization of intraocular pressure without IOP- lowering drugs.

Results

The visual acuity in the right eye, while discharged from the hospital, was 0,3. The intraocular pressure in the right eye was stabilized and amounted to 17 mm Hg.

Conclusion

Preserflo seems to be a good therapeutic option also in advanced glaucoma patients with good safety profile. The applied treatment enabled to stabilize the intraocular pressure and retain the previous visual acuity in the rigft eye.